15–20 PowerPoint slides
Use at least 30 point font size consistently throughout
10 REFERENCES
Choose a PowerPoint design, color scheme, font type, and bullet types
Organize the slides based on your headings and subheadings· Include a title slide (at the beginning) and a reference slide (at the end of the presentation)
Do not overload the slides with text and data
Use bullet points to organize your text
Keep the text abbreviated and conciseChoose a different layout for each slide
Use pictures, graphics, charts, and graphs to illustrate key points
Graphics should make a key concept clearer
Final slides should emphasize key points or leave the audience with a question to think about or answer
outline
I. Definition
II. Cause of the disease
Need to know
a. Overview: Some people are at a high risk of contracting meningococcal disease. The risks involve travel, age, community setting, and certain medical conditions (Ghebrehewet, Conrad & Marsh, (2016).
b. Meningococcal vaccination: several vaccines are available to children and adults
I. Transmission: The disease is causes by Neisseria Meningitides. It is classified as airborne disease because it is transmitted through kissing or coughing.
· Signs & symptoms: The disease present the signs and symptoms of flu-illness, and can have additional signs such as fever, headache, nausea, vomiting, altered mental status, among others (Tsang & Taha, 2016)
· Prevention: Vaccines and antibiotics appear to be the most effective (Pollard, Feavers & Cohn, 2016).
· Meningococcal conjugate vaccine (MCV4)
9 months to 55 years Menactra
2 years old to 55 years old Menveo
· Meningococcal polysaccharide vaccine (MPSV4)
· Serogroup B Meningococcal B
I. Treatment: Treatment is mainly based on the use of antibiotics (Nadel & Carcillo, 2016)
II. Conclusion
References
Brandtzaeg, P. (2006). Pathogenesis and Pathophysiology of Invasive Meningococcal Disease. Handbook of Meningococcal Disease, 427-480. doi:10.1002/3527608508.ch21
Ghebrehewet, S., Conrad, D., & Marsh, G. (2016). Meningitis and meningococcal disease. Oxford Medicine Online. doi:10.1093/med/9780198745471.003.0011
Nadel, S., & Carcillo, J. (2016). Treatment of meningococcal disease. Handbook of Meningococcal Disease Management, 75-90. doi:10.1007/978-3-319-28119-3_6
Pollard, A. J., Feavers, I., & Cohn, A. (2016). Prevention of meningococcal disease through vaccination. Handbook of Meningococcal Disease Management, 91-103. doi:10.1007/978-3-319-28119-3_7
Tsang, R., & Taha, M. (2016). Diagnosis of meningococcal disease. Handbook of Meningococcal Disease Management, 45-55. doi:10.1007/978-3-319-28119-3_4
